Bayer and ERS enter CRISPR patent licensing agreement

19-05-2016

Bayer and ERS enter CRISPR patent licensing agreement

Lukassek / Shutterstock.com

Bayer and ERS Genomics have signed a patent licensing agreement which gives Bayer access to ERS’s CRISPR/Cas9 genome-editing patents.


Bayer, ERS Genomics, patent, licensing, CRISPR/Cas9, CRISPR

LSIPR